Open Journal of Clinical Diagnostics

Vol.3 No.2(2013), Paper ID 33588, 15 pages

DOI:10.4236/ojcd.2013.32009

 

SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells

 

Changge Fang, Ingalill Avis, Caterina Bianco, Natalie Held, Jennifer Morris, Kris Ylaya, Stephen M. Hewitt, Alfred C. Aplin, Roberto F. Nicosia, Laura A. Fung, John D. Lewis, William G. Stetler-Stevenson, David S. Salomon, Frank Cuttitta

 

Angiogenesis Core Facility, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA
Angiogenesis Core Facility, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA
Tumor Growth Factor Section, Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, USA
Tumor Growth Factor Section, Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, USA
Tissue Array Research, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, USA
Tissue Array Research, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, USA 4Department of Pathology, University of Washington, Seattle, USA
Tissue Array Research, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, USA
Department of Pathology, University of Washington, Seattle, USA
Department of Pathology, University of Washington, Seattle, USA;Pathology and Laboratory Medicine Services, Veterans Administration Puget Sound Health Care System, Seattle, USA
Innovascreen Inc., New Glasgow, Canada
Innovascreen Inc., New Glasgow, Canada;Department of Oncology, University of Alberta, Edmonton, Canada
Extracellular Matrix Pathology Section, Radiation Oncology Branch, Center for Cancer Research, Bethesda, USA
Tumor Growth Factor Section, Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, USA
Angiogenesis Core Facility, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA

 

Copyright © 2013 Changge Fang, Ingalill Avis, Caterina Bianco, Natalie Held, Jennifer Morris, Kris Ylaya, Stephen M. Hewitt, Alfred C. Aplin, Roberto F. Nicosia, Laura A. Fung, John D. Lewis, William G. Stetler-Stevenson, David S. Salomon, Frank Cuttitta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Fang, C. , Avis, I. , Bianco, C. , Held, N. , Morris, J. , Ylaya, K. , Hewitt, S. , Aplin, A. , Nicosia, R. , Fung, L. , Lewis, J. , Stetler-Stevenson, W. , Salomon, D. and Cuttitta, F. (2013) SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells. Open Journal of Clinical Diagnostics, 3, 37-51. doi: 10.4236/ojcd.2013.32009.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.